-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Xeris Biopharma Holdings, Inc. quarterly/annual Revenues history and growth rate from Q1 2021 to Q1 2022.
- Xeris Biopharma Holdings, Inc. Revenues for the quarter ending March 31, 2022 was $22.1M, a 169% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual Revenues for 2021 was $49.6M, a 143% increase from 2020.